Inventor · disambiguated record
Jun Qin
Also filed as: QIN JUN
15 granted patents·11 pending applications·44 citations·filing 2006–2022
89Inventor score
Top patents by PatentIndex Score
26 records- 0183US8450343B2Gamma secretase modulatorsHUANG XIANHAI·Filed 2008·Granted May 28, 2013·9 cites·8 claims
- 0283US7763623B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2007·Granted Jul 27, 2010·9 cites·39 claims
- 0379US7723342B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2006·Granted May 25, 2010·4 cites·61 claims
- 0478US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 0578US8518975B2Gamma secretase modulatorsASLANIAN ROBERT G·Filed 2008·Granted Aug 27, 2013·5 cites·15 claims
- 0678US7737155B2Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2007·Granted Jun 15, 2010·2 cites·35 claims
- 0774US8673900B2Gamma secretase modulatorsZHU ZHAONING·Filed 2009·Granted Mar 18, 2014·2 cites·2 claims
- 0874US7750015B2Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2006·Granted Jul 6, 2010·2 cites·47 claims
- 0972US12116350B2Compounds for treating ILK-mediated diseasesCLEVELAND CLINIC FOUND·Filed 2022·Granted Oct 15, 2024·0 cites·11 claims
- 1072US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 1170US8357682B2Gamma secretase modulatorsZHU ZHAONING·Filed 2008·Granted Jan 22, 2013·1 cites·37 claims
- 1261US11524945B2Compounds for treating ILK-mediated diseasesCLEVELAND CLINIC FOUND·Filed 2019·Granted Dec 13, 2022·0 cites·20 claims
- 1360US2024368115A1Regulator containing tricyclic derivative, preparation method therefor and application thereofSHUJING BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1459US2011257156A1Gamma secretase modulatorsZHU ZHAONING·Filed 2009·Application pending·0 cites
- 1558US2024190888A1Spiro-containing derivative, and preparation method therefor and use thereofSHUJING BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1656US2023339949A1HETEROCYCLIC SUBSTITUTED FUSED y-CARBOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF AND USE THEREOFSHUJING BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1752US8809318B2Gamma secretase modulatorsZHU ZHAONING·Filed 2009·Granted Aug 19, 2014·0 cites·7 claims
- 1850US2011027264A1Gamma secretase modulators for the treatment of alzheimer's diseaseHUANG XIANHAI·Filed 2009·Application pending·0 cites
- 1950US2011053918A1Gamma secretase modulatorsZHU ZHAONING·Filed 2008·Application pending·0 cites
- 2049US2010298359A1Gamma secretase modulatorsHUANG XIANHAI·Filed 2008·Application pending·0 cites
- 2149US2011257163A1Gamma secretase modulatorsSCHERING CORP·Filed 2008·Application pending·0 cites
- 2248US2010227873A1Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2010·Application pending·0 cites
- 2344US10385034B2Flavonoid IL-17A inhibitorsCLEVELAND CLINIC FOUND·Filed 2015·Granted Aug 20, 2019·0 cites·6 claims
- 2444US2011152259A1Nitrogen-containing heterocyclic compounds and methods of use thereofPALANI ANANDAN·Filed 2011·Application pending·0 cites
- 2541US2020397808A1Treatment of steroid-resistant disease using an anthocyanin and a corticosteroidCLEVELAND CLINIC FOUND·Filed 2018·Application pending·0 cites
- 2640US8846884B2Method for enrichment and isolation of endogenous transcription factor and complexes thereof and corresponding tandem arrays of concatenated transcription factor response elementsINST OF RADIATION MEDICINE CHINA ACADEMY OF MILITARY MEDICAL SCIENCES·Filed 2012·Granted Sep 30, 2014·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Jun Qin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →